<html>
<head>PUBMED IDs for LARGE2</head>
<body bgcolor='#C5F0F2'><h1>LARGE2</h1><a href='https://pubmed.ncbi.nlm.nih.gov/15752776/'>LARGE2 facilitates the maturation of alpha-dystroglycan more effectively than LARGE.</a> March 9  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/15958417/'>Characterization of the LARGE family of putative glycosyltransferases associated with dystroglycanopathies.</a> June 17  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/19019316/'>Muscular dystrophies due to glycosylation defects.</a> November 21  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/25138275/'>Endogenous glucuronyltransferase activity of LARGE or LARGE2 required for functional modification of Î±-dystroglycan in cells and tissues.</a> February 7  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/26220087/'>Downregulation of dystroglycan glycosyltransferases LARGE2 and ISPD associate with increased mortality in clear cell renal cell carcinoma.</a> March 25  2015<br></body></html>
